$259 Million is the total value of CPWM, LLC's 122 reported holdings in Q4 2013. The portfolio turnover from Q3 2013 to Q4 2013 was 38.5% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| OMC | Omnicom Groupequities | $5,065,000 | +18.3% | 68,100 | 0.0% | 1.95% | +11.2% | |
| BRKA | Berkshire Hathaway Incequities | $1,779,000 | +5.5% | 10 | 0.0% | 0.69% | -0.9% | |
| BMY | Bristol Myers SQuibbequities | $1,298,000 | +19.0% | 24,423 | 0.0% | 0.50% | +11.8% | |
| ICGE | Internet Capital Groupequities | $559,000 | +63.5% | 30,000 | 0.0% | 0.22% | +54.3% | |
| MCHX | Marchex Incequities | $499,000 | +43.8% | 57,701 | 0.0% | 0.19% | +35.2% | |
| VEU | Vanguard Ftse All - World Ex - US Index ETF Fundsequities | $431,000 | +14.6% | 8,500 | 0.0% | 0.17% | +7.8% | |
| IWN | iShares Russell 2000 Value Index Fundequities | $366,000 | +15.8% | 3,680 | 0.0% | 0.14% | +8.5% | |
| Foundation Bancorpequities | $257,000 | +31.1% | 32,571 | 0.0% | 0.10% | +23.8% | ||
| USCI | U.S. Commodity Index Fundequities | $238,000 | +4.8% | 4,246 | 0.0% | 0.09% | -1.1% | |
| GSK | Glaxosmithklineequities | $227,000 | +7.1% | 4,251 | 0.0% | 0.09% | +1.1% | |
| PPR | Voya Prime Rate TRUSTequities | $188,000 | -8.7% | 32,335 | 0.0% | 0.07% | -14.1% | |
| ILIU | Interleukin Genetics Incequities | $106,000 | -16.5% | 302,271 | 0.0% | 0.04% | -21.2% | |
| JSDA | Jones Soda Coequities | $24,000 | -25.0% | 50,000 | 0.0% | 0.01% | -30.8% | |
| First Horizon National Corporation (NV)equities | $0 | – | 260,480 | 0.0% | 0.00% | – | ||
| HRZB | Horizon Financial (NV)equities | $0 | – | 17,044 | 0.0% | 0.00% | – | |
| BDYS | Bodyscan Corporation (NV)equities | $0 | – | 17,250 | 0.0% | 0.00% | – | |
| 1/100000 Aig 2021wtsequities | $0 | – | 21,259 | 0.0% | 0.00% | – | ||
| NRGXQ | Neurologix Inc Newequities | $0 | – | 11,000 | 0.0% | 0.00% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2017-06-09
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| STARBUCKS CORP - COM | 44 | Q3 2022 | 30.4% |
| ISHARES TR - RUS 1000 GRW ETF | 44 | Q3 2022 | 9.8% |
| MICROSOFT ESPP PLAN | 44 | Q3 2022 | 9.2% |
| PACCAR INC - COM | 44 | Q3 2022 | 14.3% |
| Omeros Corp. (Restricted Shares) | 44 | Q3 2022 | 8.5% |
| ISHARES TR - CORE US AGGBD ET | 44 | Q3 2022 | 4.9% |
| ISHARES TR - SH TR CRPORT ETF | 44 | Q3 2022 | 4.1% |
| ISHARES TR - TIPS BD ETF | 44 | Q3 2022 | 6.2% |
| ISHARES TR - CORE S&P500 ETF | 44 | Q3 2022 | 5.5% |
| ISHARES TR - INTL DEVPPTY ETF | 44 | Q3 2022 | 3.8% |
View CPWM, LLC's complete holdings history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2022-11-14 |
| 13F-HR | 2022-08-12 |
| 13F-HR | 2022-05-13 |
| 13F-HR | 2022-02-14 |
| 13F-HR | 2021-11-12 |
| 13F-HR | 2021-08-13 |
| 13F-HR | 2021-05-14 |
| 13F-HR | 2021-02-12 |
| 13F-HR | 2020-11-13 |
| 13F-HR | 2020-08-13 |
View CPWM, LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.